Literature DB >> 2852567

Blood polymorphonuclear behavior in patients with ankylosing spondylitis.

A el Abbouyi1, J L Paul, M Roch-Arveiller, L Moachon, M Dougados, J P Giroud, B Amor, D Raichvarg.   

Abstract

The oxidative metabolism and chemotaxis of polymorphonuclear leukocytes (PMNs) collected from patients with ankylosing spondylitis and healthy subjects were studied in parallel. The responses to opsonized zymosan were significantly lowered considering oxygen consumption and release of superoxide anions, whereas no modification of these parameters to phorbol myristate acetate and calcium ionophore (A 23187) stimulations were observed. A seric factor was not involved but the characterization of a specific intrinsic abnormality of the PMNs needs further investigations. PMN chemotaxis, assessed by two methods performed in parallel, remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852567

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  The phagocyte oxidative metabolism function in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; D A Vuitton
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis.

Authors:  M Leirisalo-Repo; A Lauhio; H Repo
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

3.  Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence.

Authors:  M Ristola; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

4.  The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence.

Authors:  K J Ho; P Q Chen; C Y Chang; F J Lu
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.